1
Eric P Berg, Ronald J Tuch, Michael Dror, Rodney G Wolff: Intravascular stent and method. Medtronic, Daniel W Latham, Harold R Patton, November 7, 1995: US05464650 (867 worldwide citation)

A method for making an intravascular stent by applying to the body of a stent a solution which includes a solvent, a polymer dissolved in the solvent and a therapeutic substance dispersed in the solvent and then evaporating the solvent. The inclusion of a polymer in intimate contact with a drug on t ...


2
Ronald J Tuch: Intravascular stent and method. Medtronic, Daniel W Latham, Harold R Patton, April 29, 1997: US05624411 (566 worldwide citation)

A method for making an intravascular stent by applying to the body of a stent a therapeutic substance and then overcoating the therapeutic substance with a porous polymer. The inclusion of a porous polymer in intimate contact with a drug on the stent allows the drug to be retained on the stent durin ...


3
Ronald J Tuch: Intravascular stent and method. Medtronic, Daniel W Latham, Harold R Patton, October 21, 1997: US05679400 (548 worldwide citation)

A method for making an intravascular stent by applying to the body of a stent a solution which includes a solvent, a polymer dissolved in the solvent and a therapeutic substance dispersed in the solvent and then evaporating the solvent. The inclusion of a polymer in intimate contact with a drug on t ...


4
Ronald J Tuch: Method for delivering a therapeutic substance to a body lumen. Medtronic, Daniel W Latham, Harold R Patton, October 20, 1998: US05824048 (515 worldwide citation)

A method for delivering a therapeutic substance to a body lumen utilizing an intravascular stent having a coating comprising a polymer and a therapeutic substance in a solid/solid solution with the polymer. The coating comprises a first coating layer nearer the stent body having a first concentratio ...


5
Ronald J Tuch: Blood contacting medical device and method. Medtronic, Daniel W Latham, Harold R Patton, February 2, 1999: US05865814 (447 worldwide citation)

A a blood-contacting medical device with improved biocompatibility. The device is coated with a layer of water-soluble heparin, overlaid by a porous polymeric coating through which the heparin can elute. The inclusion of a porous polymer in intimate contact with a heparin on the device controls the ...


6
Ronald J Tuch: Intravasoular stent and method. Medtronic, Daniel W Latham, Harold R Patton, July 7, 1998: US05776184 (398 worldwide citation)

A device for delivery of a therapeutic substance into a body lumen including a polymer in intimate contact with a drug on a stent allows the drug to be retained on the stent during expansion of the stent and also controls the administration of drug following implantation. The adhesion of the coating ...


7
Eric P Berg, Ronald J Tuch, Michael Dror, Rodney G Wolff: Intravascular stent and method. Medtronic, Daniel W Latham, Harold R Patton, November 17, 1998: US05837008 (365 worldwide citation)

A method for making an intravascular stent by applying to the body of a stent a solution which includes a solvent, a polymer dissolved in the solvent and a therapeutic substance dispersed in the solvent and then evaporating the solvent. The inclusion of a polymer in intimate contact with a drug on t ...


8
Thomas Q Dinh, Ronald J Tuch, Robert S Schwartz: Drug eluting stent. Medtronic, Daniel W Latham, Harold R Patton, December 16, 1997: US05697967 (306 worldwide citation)

An intraluminal stent comprising fibrin and an elutable drug is capable of providing a treatment of restenosis.


9
Thomas Q Dinh, Ronald J Tuch, Robert S Schwartz: Drug eluting stent. Medtronic, Daniel W Latham, Harold R Patton, January 7, 1997: US05591227 (306 worldwide citation)

An intraluminal stent comprising fibrin and an elutable drug is capable of providing a treatment of restenosis.


10
Ronald J Tuch: Blood-contacting medical device and method. Medtronic, Daniel W Latham, Harold R Patton, October 13, 1998: US05820917 (266 worldwide citation)

A method for making a blood-contacting medical device with improved biocompatibility by applying to the blood-contacting surface an aqueous solution of heparin and then overcoating the heparin with a porous polymer. The inclusion of a porous polymer in intimate contact with a heparin on the device c ...